XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Corrections to the Consolidated Statements Of Operations (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total net sales $ 1,103,000,000 $ 1,040,000,000 $ 1,062,000,000 $ 1,026,000,000 $ 1,076,000,000 $ 883,000,000 $ 499,000,000 $ 881,000,000 $ 4,231,000,000 $ 3,339,000,000 $ 4,022,000,000
Cost of products sold 499,000,000 471,000,000 467,000,000 447,000,000 509,000,000 451,000,000 317,000,000 406,000,000 1,884,000,000 1,683,000,000 1,858,000,000
Gross profit 604,000,000 569,000,000 595,000,000 579,000,000 567,000,000 432,000,000 182,000,000 475,000,000 2,347,000,000 1,656,000,000 2,164,000,000
Selling, general, and administrative expenses 377,000,000 395,000,000 393,000,000 386,000,000 373,000,000 313,000,000 259,000,000 357,000,000 1,551,000,000 1,302,000,000 1,587,000,000
Research and development expenses 49,000,000 39,000,000 43,000,000 40,000,000 38,000,000 29,000,000 20,000,000 36,000,000 171,000,000 123,000,000 143,000,000
Goodwill impairment       0       157,000,000 0 157,000,000 0
Restructuring and other costs - non-cash 6,000,000 3,000,000 5,000,000 3,000,000 15,000,000 18,000,000 2,000,000 42,000,000 17,000,000 77,000,000 81,000,000
Operating income 172,000,000 132,000,000 154,000,000 150,000,000 141,000,000 72,000,000 (99,000,000) (117,000,000) 608,000,000 (3,000,000) 353,000,000
Interest expense, net 12,000,000 14,000,000 15,000,000 14,000,000 15,000,000 14,000,000 11,000,000 6,000,000 55,000,000 46,000,000 27,000,000
Other expense (income), net 4,000,000 5,000,000 8,000,000 (9,000,000) (3,000,000) 1,000,000 4,000,000 (1,000,000) 8,000,000 1,000,000 (12,000,000)
Income (loss) before income taxes 156,000,000 113,000,000 131,000,000 145,000,000 129,000,000 57,000,000 (114,000,000) (122,000,000) 545,000,000 (50,000,000) 338,000,000
Provision for income taxes 37,000,000 29,000,000 35,000,000 33,000,000 24,000,000 9,000,000 (22,000,000) 12,000,000 134,000,000 23,000,000 82,000,000
Net income (loss) 119,000,000 84,000,000 96,000,000 112,000,000 105,000,000 48,000,000 (92,000,000) (134,000,000) 411,000,000 (73,000,000) 256,000,000
Less: Net income (loss) attributable to noncontrolling interests 0   0 0 0   (1,000,000) 0 0 0 0
Net income attributable to Dentsply Sirona $ 119,000,000 $ 84,000,000 $ 96,000,000 $ 112,000,000 $ 105,000,000 $ 47,000,000 $ (91,000,000) $ (134,000,000) $ 411,000,000 $ (73,000,000) $ 256,000,000
Net income (loss) per common share attributable to Dentsply Sirona:                      
Basic (in dollars per share) $ 0.55 $ 0.39 $ 0.44 $ 0.51 $ 0.48 $ 0.22 $ (0.42) $ (0.61) $ 1.88 $ (0.33) $ 1.15
Diluted (in dollars per share) $ 0.54 $ 0.38 $ 0.43 $ 0.51 $ 0.48 $ 0.22 $ (0.42) $ (0.61) $ 1.87 $ (0.33) $ 1.14
As Previously Issued                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total net sales $ 1,088,000,000 $ 1,069,000,000 $ 1,067,000,000 $ 1,027,000,000 $ 1,082,000,000 $ 895,000,000 $ 491,000,000 $ 874,000,000 $ 4,251,000,000 $ 3,342,000,000 $ 4,029,000,000
Cost of products sold 495,000,000 478,000,000 469,000,000 448,000,000 511,000,000 453,000,000 315,000,000 406,000,000 1,890,000,000 1,685,000,000 1,864,000,000
Gross profit 593,000,000 591,000,000 598,000,000 579,000,000 571,000,000 442,000,000 176,000,000 468,000,000 2,361,000,000 1,657,000,000 2,165,000,000
Selling, general, and administrative expenses 374,000,000 394,000,000 398,000,000 385,000,000 377,000,000 315,000,000 261,000,000 359,000,000 1,551,000,000 1,312,000,000 1,580,000,000
Research and development expenses 59,000,000 35,000,000 40,000,000 37,000,000 44,000,000 27,000,000 18,000,000 34,000,000 171,000,000 123,000,000 143,000,000
Goodwill impairment       0       157,000,000 0 157,000,000 0
Restructuring and other costs - non-cash 6,000,000 3,000,000 5,000,000 3,000,000 15,000,000 18,000,000 1,000,000 43,000,000 17,000,000 77,000,000 81,000,000
Operating income 154,000,000 159,000,000 155,000,000 154,000,000 135,000,000 82,000,000 (104,000,000) (125,000,000) 622,000,000 (12,000,000) 361,000,000
Interest expense, net 12,000,000 13,000,000 16,000,000 14,000,000 15,000,000 14,000,000 11,000,000 7,000,000 55,000,000 47,000,000 28,000,000
Other expense (income), net 4,000,000 8,000,000 5,000,000 (9,000,000) (3,000,000) 1,000,000 5,000,000 (2,000,000) 8,000,000 1,000,000 (12,000,000)
Income (loss) before income taxes 138,000,000 138,000,000 134,000,000 149,000,000 123,000,000 67,000,000 (120,000,000) (130,000,000) 559,000,000 (60,000,000) 345,000,000
Provision for income taxes 36,000,000 35,000,000 35,000,000 32,000,000 24,000,000 13,000,000 (24,000,000) 10,000,000 138,000,000 23,000,000 82,000,000
Net income (loss) 102,000,000 103,000,000 99,000,000 117,000,000 99,000,000 54,000,000 (96,000,000) (140,000,000) 421,000,000 (83,000,000) 263,000,000
Less: Net income (loss) attributable to noncontrolling interests 0   0 0 0   (1,000,000) 0 0 0 0
Net income attributable to Dentsply Sirona $ 102,000,000 $ 103,000,000 $ 99,000,000 $ 117,000,000 $ 99,000,000 $ 53,000,000 $ (95,000,000) $ (140,000,000) $ 421,000,000 $ (83,000,000) $ 263,000,000
Net income (loss) per common share attributable to Dentsply Sirona:                      
Basic (in dollars per share) $ 0.47 $ 0.47 $ 0.45 $ 0.53 $ 0.45 $ 0.25 $ (0.44) $ (0.63) $ 1.93 $ (0.38) $ 1.18
Diluted (in dollars per share) $ 0.47 $ 0.47 $ 0.45 $ 0.53 $ 0.45 $ 0.25 $ (0.44) $ (0.63) $ 1.91 $ (0.38) $ 1.17
Adjustment                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total net sales $ 15,000,000 $ (29,000,000) $ (5,000,000) $ (1,000,000) $ (6,000,000) $ (12,000,000) $ 8,000,000 $ 7,000,000 $ (20,000,000) $ (3,000,000) $ (7,000,000)
Cost of products sold 4,000,000 (7,000,000) (2,000,000) (1,000,000) (2,000,000) (2,000,000) 2,000,000 0 (6,000,000) (2,000,000) (6,000,000)
Gross profit 11,000,000 (22,000,000) (3,000,000) 0 (4,000,000) (10,000,000) 6,000,000 7,000,000 (14,000,000) (1,000,000) (1,000,000)
Selling, general, and administrative expenses 3,000,000 1,000,000 (5,000,000) 1,000,000 (4,000,000) (2,000,000) (2,000,000) (2,000,000) 0 (10,000,000) 7,000,000
Research and development expenses (10,000,000) 4,000,000 3,000,000 3,000,000 (6,000,000) 2,000,000 2,000,000 2,000,000 0 0 0
Goodwill impairment       0       0 0 0 0
Restructuring and other costs - non-cash 0 0 0 0 0 0 1,000,000 (1,000,000) 0 0 0
Operating income 18,000,000 (27,000,000) (1,000,000) (4,000,000) 6,000,000 (10,000,000) 5,000,000 8,000,000 (14,000,000) 9,000,000 (8,000,000)
Interest expense, net 0 1,000,000 (1,000,000) 0 0 0 0 (1,000,000) 0 (1,000,000) (1,000,000)
Other expense (income), net 0 (3,000,000) 3,000,000 0 0 0 (1,000,000) 1,000,000 0 0 0
Income (loss) before income taxes 18,000,000 (25,000,000) (3,000,000) (4,000,000) 6,000,000 (10,000,000) 6,000,000 8,000,000 (14,000,000) 10,000,000 (7,000,000)
Provision for income taxes 1,000,000 (6,000,000) 0 1,000,000 0 (4,000,000) 2,000,000 2,000,000 (4,000,000) 0 0
Net income (loss) 17,000,000 (19,000,000) (3,000,000) (5,000,000) 6,000,000 (6,000,000) 4,000,000 6,000,000 (10,000,000) 10,000,000 (7,000,000)
Less: Net income (loss) attributable to noncontrolling interests 0   0 0 0   0 0 0 0 0
Net income attributable to Dentsply Sirona $ 17,000,000 $ (19,000,000) $ (3,000,000) $ (5,000,000) $ 6,000,000 $ (6,000,000) $ 4,000,000 $ 6,000,000 $ (10,000,000) $ 10,000,000 $ (7,000,000)
Net income (loss) per common share attributable to Dentsply Sirona:                      
Basic (in dollars per share) $ 0.08 $ (0.08) $ (0.01) $ (0.02) $ 0.03 $ (0.03) $ 0.02 $ 0.02 $ (0.05) $ 0.05 $ (0.03)
Diluted (in dollars per share) $ 0.07 $ (0.09) $ (0.02) $ (0.02) $ 0.03 $ (0.03) $ 0.02 $ 0.02 $ (0.04) $ 0.05 $ (0.03)